Real-Time PCR, Digital PCR And End-Point PCR Market Report 2026

Real-Time PCR, Digital PCR And End-Point PCR Market Overview

• Real-Time PCR, Digital PCR And End-Point PCR market size has reached to $41.55 billion in 2025 • Expected to grow to $67.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.5% • Growth Driver: Elevated Prevalence Of Infectious Diseases Fueling Growth In The Real-Time PCR, Digital PCR, And End-Point PCR Market • Market Trend: Innovations In Digital PCR Technology Enhance Precision And Clinical Applicability In Real-Time PCR Applications • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Real-Time PCR, Digital PCR And End-Point PCR Market?

Real-time PCR (polymerase chain reaction), digital PCR, and endpoint PCR are different techniques in molecular biology and genetic analysis used to amplify and analyze DNA samples. Real-time polymerase chain reaction (PCR) is a laboratory technique to amplify and quantify DNA or RNA molecules. Digital PCR is the third generation of PCR that enables precise quantification by segregating a sample into numerous isolated compartments. Endpoint PCR, or conventional PCR, refers to a fundamental molecular biology technique used to amplify a specific DNA sequence from a sample. These PCR techniques are used in various clinical applications, such as bacteria detection, DNA fingerprinting, and genetic disorder diagnosis. The main products of real-time PCR, digital PCR, and end-point PCR are instruments, consumables and reagents, software, and services. Instruments refer to devices, tools, or equipment specifically designed and used for various purposes, including measurement, analysis, manipulation, or control of physical, chemical, or biological phenomena. The various technologies such as quantitative, end-point PCR, and digital it is used for clinical, research, forensic, and other applications by different end users including hospitals, diagnostic labs, pharma, biotech, and contract research organizations.

What Is The Real-Time PCR, Digital PCR And End-Point PCR Market Growth Forecast?

The real-time pcr, digital pcr and end-point pcr market size is expected to see rapid growth in the next few years. It will grow to $67.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine diagnostics, rising investments in genomics research, expansion of point-of-care molecular testing, growing demand for ultra-sensitive detection methods, increased automation in molecular laboratories. Major trends in the forecast period include increasing adoption of digital pcr for precision quantification, rising demand for high-throughput pcr systems, growing use of multiplex pcr assays, expansion of automated pcr workflows, enhanced focus on data accuracy and sensitivity.

Global Real-Time PCR, Digital PCR And End-Point PCR Market Segmentation

1) By Product: Instruments, Consumables And Reagents, Software And Services 2) By Technology: Quantitative, End-Point Polymerase Chain Reaction (PCR), Digital 3) By Applications: Clinical, Research, Forensic, Other Applications 4) By End User: Hospital, Diagnostic Labs, Pharma, Biotech, Contract Research Organizations Subsegments: 1) By Instruments: Real-Time PCR Systems, Digital PCR Systems, End-Point PCR Systems 2) By Consumables And Reagents: PCR Plates And Tubes, Primers And Probes, PCR Master Mix, DNA Polymerases And Nucleotides 3) By Software And Services: Analysis Software, Data Management Software, Calibration And Maintenance Services, Training And Support Services

What Is The Driver Of The Real-Time PCR, Digital PCR And End-Point PCR Market?

The increase in the incidence of infectious diseases is expected to propel the growth of the real-time PCR, digital PCR, and end-point PCR markets going forward. Infectious diseases refer to illnesses caused by the invasion and multiplication of pathogenic microorganisms, including bacteria, viruses, fungi, and parasites. Real-time PCR, digital PCR, and end-point PCR are utilized in infectious diseases to quantify specific pathogens or their genetic material, monitor disease progression, and rapidly diagnose infections such as HIV, hepatitis, respiratory viruses, and tuberculosis. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the increase in the incidence of infectious diseases will drive the growth of the cephalosporin market.

Key Players In The Global Real-Time PCR, Digital PCR And End-Point PCR Market

Major companies operating in the real-time pcr, digital pcr and end-point pcr market are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Co., Agilent Technologies Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc. , Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG , Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.

Global Real-Time PCR, Digital PCR And End-Point PCR Market Trends and Insights

Major companies operating in the real-time PCR, digital PCR, and end-point PCR markets are focusing on developing next-generation platforms to enhance assay sensitivity, improve precision, and elevate overall clinical performance. These advancements aim to enable highly accurate detection of low-abundance nucleic acids, rare mutations, and copy number variations (CNVs), supporting both research and clinical diagnostic applications. Digital PCR, in particular, offers absolute quantification capabilities, making it valuable for applications requiring high sensitivity and reproducibility. For instance, in September 2024, QIAGEN N.V., a Germany-based provider of sample and assay technologies for molecular diagnostics, launched the QIAcuityDx Digital PCR System for clinical oncology diagnostics, along with over 100 newly validated assays through its GeneGlobe platform. The system integrates sample partitioning, thermocycling, and imaging into a single automated workflow, facilitating streamlined operations for clinical and research laboratories. Designed to support applications such as non-invasive liquid biopsy testing, the QIAcuityDx platform underscores QIAGEN’s commitment to advancing diagnostic accuracy and improving clinical outcomes.

What Are Latest Mergers And Acquisitions In The Real-Time PCR, Digital PCR And End-Point PCR Market?

In April 2024, Bio-Rad Laboratories Inc., a US-based research company that specializes in providing real-time PCR, digital PCR, partnered with Oncocyte Corporation. The partnership aims to develop and commercialize advanced transplant monitoring products using Droplet Digital PCR technology, enhancing non-invasive assessments of organ health through sensitive analysis of cell-free DNA biomarkers to improve patient outcomes in transplant care. Oncocyte Corporation is a US-based biotechnology research company that specializes in precision diagnostics for cancer and transplant monitoring.

Regional Outlook

North America was the largest region in the real-time PCR, digital PCR, and end-point PCR market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Real-Time PCR, Digital PCR And End-Point PCR Market?

The real-time PCR, digital PCR, and end-point PCR market include revenues earned by entities by providing services such as quantitative analysis, real-time monitoring, high sensitivity and specificity, gene expression analysis, absolute quantification, rare event detection, qualitative detection, and molecular cloning. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time PCR, digital PCR, and end-point PCR market also include sales of thermal cyclers, fluorescent probes, quantitative data output, standard curves, real-time PCR reagents, partitioning chips or plates, digital PCR instruments, and PCR master mixes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Real-Time PCR, Digital PCR And End-Point PCR Market Report 2026?

The real-time pcr, digital pcr and end-point pcr market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the real-time pcr, digital pcr and end-point pcr industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.